BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, December 21, 2025
See today's BioWorld
Home
» Other news to note for Jan. 30, 2024
To read the full story,
subscribe
or
sign in
.
Other news to note for Jan. 30, 2024
Jan. 30, 2024
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Agilent, Alpha-9, Arcus, Avrobio, Bridgebio Can-Fite, Cidara, Concentra, Cormedix, Ewopharma, Fabentech, Gilead, Incyte, Invitae, Ionis, ITM, J&J, Maxcyte, Mundipharma, Nanobio, Qubit, Tetonic, Theseus, Vaxxinity, Vect-Horus, Wugen.
BioWorld
Briefs
Other news to note